19
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 60MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB
18
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 40MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB
17
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB
16
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 70MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB
15
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 50MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB
14
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 30MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB
13
Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding application number 214484.
Regulatory Information RX
With a dosage strength 10MG
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug No
Approved since 2023-08-25
Therapeutic Equivalence (TE) Code AB